Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    EP03.01 - Epidemiology

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Epidemiology
    • +

      EP03.01-009 - BrainMets-Cross-Sectional Study To Identify The Presence Of Brain Metastasis At Diagnosis Of Advanced NSCLC EGFRm in Portuguese Patients

      Presenter: Maria Encarnação Teixeira

      • Abstract

      Loading...

  • +

    EP04.01 - Global Health, Health Services Research, and Health Economics - Cost Issues

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Global Health, Health Services Research, and Health Economics - Cost Issues
    • +

      EP04.01-011 - Diagnostic Approach and Treatment of Lung Cancer Patients in Portugal: Portuguese Lung Cancer Study Group Survey

      Presenter: Fernanda Estevinho

      • Abstract

      Loading...

  • +

    EP05.03 - Locally Advanced Non-small Cell Lung Cancer - Surgery

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Locally Advanced Non-small Cell Lung Cancer - Surgery
    • +

      EP05.03-006 - Real-World Treatment Pathways In Stage III Non-Small Cell Lung Cancer in Portugal (PICTuRE): An Interim Analysis Of Surgical Patients

      Presenter: Maria Encarnação Teixeira

      • Abstract

      Loading...

  • +

    EP16.03 - Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Tumor Biology and Biomarkers - Molecular Profiling and Targeted Therapeutics
    • +

      EP16.03-011 - The European Program for ROutine Testing of Patients with Advanced Lung Cancer (EPROPA) 1 Year Activity

      Presenter: Francesco Passiglia

      • Abstract

      Loading...

  • +

    OA15 - Patient Selection in Advanced NSCLC Immunotherapy

    • 14:30 - 15:30
    • 8/09/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Immunotherapy
    • +

      Session Moderator

      14:32 - 00:00  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      Session Moderator

      14:32 - 00:00  |  Presenter: António Araújo

      • Abstract

      Loading...

    • +

      OA15.01 - Session Introduction

      14:30 - 14:31  |  Presenter: Pilar Garrido

      • Abstract

      Loading...

    • +

      OA15.02 - Session Introduction

      14:31 - 14:32  |  Presenter: António Araújo

      • Abstract

      Loading...

    • +

      OA15.03 - Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+ NSCLC: Primary Analysis from JAVELIN Lung 100

      14:32 - 14:42  |  Presenter: Martin Reck

      • Abstract

      Loading...

    • +

      OA15.04 - Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC

      14:42 - 14:52  |  Presenter: Solange Peters

      • Abstract

      Loading...

    • +

      OA15.05 - HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy

      14:52 - 15:02  |  Presenter: Benjamin Besse

      • Abstract

      Loading...

    • +

      OA15.06 - Pooled Analysis of Outcomes With Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer

      15:02 - 15:12  |  Presenter: Delvys Rodriguez-Abreu

      • Abstract

      Loading...

    • +

      OA15.07 - Discussant

      15:12 - 15:22  |  Presenter: Puey Ling Chia

      • Abstract

      Loading...

    • +

      OA15.08 - Live Q&A

      15:22 - 15:30

      • Abstract

      Loading...